RNAi-Based Strategies for Cyclooxygenase-2 Inhibition in Cancer
Open Access
- 13 June 2010
- journal article
- review article
- Published by Wiley in Journal of Biomedicine and Biotechnology
- Vol. 2010, 1-11
Abstract
Cyclooxygenase-2 (COX-2) enzyme has been involved in the tumorigenesis and in the progression of colorectal cancer (CRC). The use of traditional nonsteroidal anti-inflammatory drugs (NSAIDs) or selective COX-2 inhibitors has been proposed for the prevention and the treatment of this relevant neoplastic disease. In the light of an innovative alternative to these pharmacological approaches, we review here the possible strategies to achieve a strong and selective inhibition of COX-2 enzyme by using the mechanism of RNA Interference (RNAi) targeted against its mRNA. Anti-COX-2 siRNA molecules (siCOX-2) can be generated in CRC cells from short hairpin RNA (shRNA) precursors, delivered in vitro by a retroviral expression system, and induce a significant and stable silencing of overexpressed COX-2 in human colon cancer cells. As a safer alternative to viral approach, nonpathogenic bacteria (E. coli) can be engineered to invade eukaryotic cells and to generate siCOX-2 molecules in cancer cells. Moreover, the involvement of miRNAs in COX-2 posttranscriptional regulation opens up the possibility to exploit an endogenous silencing mechanism to knockdown overexpressed COX-2. Thus, these recent strategies disclose new challenging perspectives for the development of clinically compatible siRNA or miRNA capable of selectively inhibiting COX-2 enzyme.Keywords
Funding Information
- Ministry of Education, Universities and Research (FIRB 2003 RBNE03FMCJ, PRIN 2008MT34AP)
- Ministry of Education, Universities and Research (FIRB 2003 RBNE03FMCJ, PRIN 2008MT34AP)
This publication has 92 references indexed in Scilit:
- MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cellsExperimental Cell Research, 2009
- Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNACancer Gene Therapy, 2008
- miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesisNature Neuroscience, 2008
- Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cellsOncogene, 2008
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaJAMA, 2008
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathwaysNature, 2006
- RNA interference as a key to knockdown overexpressed cyclooxygenase-2 gene in tumour cellsBritish Journal of Cancer, 2006
- MicroRNA expression profiles classify human cancersNature, 2005
- Induction of an interferon response by RNAi vectors in mammalian cellsNature Genetics, 2003
- Expression profiling reveals off-target gene regulation by RNAiNature Biotechnology, 2003